Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.22.00096
Abstract: PURPOSE Universal cancer peptide–based vaccine (UCPVax) is a therapeutic vaccine composed of two highly selected helper peptides to induce CD4+ T helper-1 response directed against telomerase. This phase Ib/IIa trial was designed to test the… read more here.
Keywords: year; universal cancer; phase iia; phase ... See more keywords
Rapid One-Step Plasma Test for the Electrochemical and Colorimetric Detection of a Universal Cancer Biomarker.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical chemistry"
DOI: 10.1373/clinchem.2018.300723
Abstract: Despite the remarkable diagnostic and therapeutic advances in recent years, cancer continues to rank as the second leading cause of global deaths, accounting for 9.6 million deaths in 2018 (1). One of the reasons cancer… read more here.
Keywords: cancer biomarker; dna; cancer cells; cancer ... See more keywords